My site

Takeda Receives Positive CHMP Opinion for Subcutaneous Formulation of Vedolizumab for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease

− If approved, the additional treatment modality will provide more options for how patients in Europe receive the gut-selective biologic vedolizumab

− Recommendation brings vedolizumab one step closer to becoming the only maintenance therapy with both intravenous and subcutaneous formulation options for patients with ulcerative colitis or Crohn’s disease

OSAKA, Japan-Friday 28 February 2020 [ AETOS Wire ... Read more »

RAS AL KHAIMAH, United Arab Emirates-Monday 24 February 2020 [ AETOS Wire ]

The American University of Ras Al Khaimah (AURAK) and the British Council have signed an agreement for AURAK to act as a center for the IELTS exam administered by the British Council.

The International English Language Testing System (IELTS) is an international standardized test of English language proficiency for non-native speakers of English.

Under the agreement, AURAK will provide information to potential candidates about the IELTS, register candidates, and act as the venue for the test. According to the deal, the British Council will be responsible for administering the exams.

President of AURAK, Professor Hassan Hamdan Al Alkim, signed the deal on behalf of the University and Mr. Deep Adhikari did so for the British Council. The deal is due to run until the end of 2020 but can be extended by mutual agreement.

The British Council also agreed to cooperate in future ... Read more »

RICHARDSON, Texas-Friday 28 February 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Mavenir, the industry’s only end-to-end cloud-native, Network Software Provider and MTI announce the first commercial portfolio of OpenRAN RRUs with the O-RAN interface. The initial portfolio consists of 2x20W RRUs for B3, B20, B7 and 2x40W for B5, B28, B71 with general availability in Q2 2020. More variants and additional band support will be added over time.

This portfolio underpins the ability to start transitioning from walled garden systems based on proprietary interfaces to a wider, multi-supplier ecosystem that enables faster innovation and lower total cost of ownership, based on OpenRAN principles.

As the RRU is fully specified by 3GPP for the air interface and O-RAN for the RRU to DU interface, MNOs will have the ability to choose best-of-breed components and have the flexibility to choose from an increasing number of RRU and end-to-end vendors.

The key goals of ... Read more »

VMware & Dell Technologies partner to enable focus on faster deployments with lower costs via containerized- and micro-serviced 5G end-to-end solutions

RICHARDSON, Texas-Friday 28 February 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Mavenir has announced integration of its 5G cloud-native telecom network functions (CNFs) with VMware’s container-ready Telco Cloud running on Dell Technologies’ edge computing solutions 5G deployments. Mavenir’s 5G deployments, pre-integrated and tested on Dell and VMware infrastructure will help speed deployments, simplify and reduce barriers for deploying 5G while providing new capabilities, including:

    Integration of open source Container as a Service (CaaS) and Platform as a Service (PaaS) with Mavenir’s microservices-based 4G/5G solutions including packet core and 4G/5G vRAN network functions and VMware’s Telco Cloud infrastructure. This allows Mobile Network Operators and Enterprises ... Read more »

Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform

• Boehringer Ingelheim will work with Trutino Biosciences to access the company’s On-Demand-CytokineTM (ODC) platform to develop new cancer immunology compounds

• The partners aim to develop safer, more tolerable and more effective cytokine therapies for single agent and novel combinations with Boehringer Ingelheim’s innovative cancer vaccine, oncolytic virus, T cell engager and myeloid-targeting therapies